Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending October 29, 2014. The document serves as a notification of transactions involving directors, persons discharging managerial responsibility, or connected persons, in accordance with DTR 3.1.4R(1)(a).
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to a specific director transaction and does not contain financial performance data.
Material Changes
The filing details a change in the shareholding interest of Mr. S Dingemans, a Director. On October 29, 2014, he was granted 238 share options over Ordinary Shares under the GlaxoSmithKline plc ShareSave Plan 2012. The option price was set at £11.31 per share.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Key Facts for Investors to Verify
- Confirmation of the grant of 238 share options to Director Mr. S Dingemans.
- Verification of the option price of £11.31 per share.
- Confirmation that the transaction occurred under the ShareSave Plan 2012 on October 29, 2014.